GB:0IMT Stock Latest News
Company AnnouncementsPhotocure ASA Earnings Call Signals Ambitious Growth4d ago
Company AnnouncementsPhotocure lifts 2026 growth outlook as it builds broader bladder cancer diagnostics platform5d ago
Company AnnouncementsPhotocure Grants Share Options to New CFO Under Long-Term Incentive Plan6d ago
Company AnnouncementsPhotocure Strengthens Executive Team With Appointment of Veteran CFO1w ago
Company AnnouncementsPhotocure Sets Date for Third-Quarter 2026 Results and Investor Webcast1w ago
Company AnnouncementsFDA Move to Ease Regulatory Pathway Seen as Catalyst for Photocure’s Bladder Cancer Technology2M agoCompany AnnouncementsPhotocure Study Finds Blue Light Cystoscopy Boosts Bladder Cancer Detection Without Raising Costs2M ago
Company AnnouncementsPhotocure Board Members Boost Shareholdings, Signaling Confidence in Uro-Oncology Strategy2M ago
Company AnnouncementsPhotocure escalates arbitration in Cevira milestone dispute with Asieris3M ago- Company AnnouncementsPhotocure ASA Earnings Call Signals Growth-Driven Strategy3M ago
Company AnnouncementsPhotocure Grants Executive Share Options to Align Leadership With Shareholder Value3M ago
Company AnnouncementsPhotocure lifts growth outlook as bladder cancer diagnostics strategy accelerates3M ago
Company AnnouncementsPhotocure to Present Q2 2026 Results in Live Investor Webcast3M ago
Company AnnouncementsPhotocure shareholders approve key resolutions at annual general meeting4M ago
Company AnnouncementsPhotocure and Artera launch AI-driven bladder cancer diagnostics collaboration4M ago
Company AnnouncementsPhotocure Calls Fully Virtual Annual General Meeting for 26 June 20265M ago- Company AnnouncementsPhotocure’s Blue Light Cystoscopy Data Underscore Clinical Edge and Cost Neutrality5M ago
Company AnnouncementsPhotocure lifts Q1 revenues on BLC adoption and Cevira milestones5M agoCompany AnnouncementsPhotocure’s Blue Light Cystoscopy Shown Cost-Effective in New Health Economics Study6M ago